Creative Medical Technology Holdings (CELZ) Notes Payables (2011 - 2021)
Creative Medical Technology Holdings (CELZ) posted quarterly Notes Payables of $117267.0 for Q2 2021, down 95.83% year-over-year from $2.8 million in Q2 2020, and down 94.85% quarter-over-quarter from $2.3 million in Q1 2021.
Creative Medical Technology Holdings (CELZ) Notes Payables (2011 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Notes Payables for 8 consecutive years, with $117267.0 the latest figure, recorded in Q2 2021.
- In Q2 2021, Notes Payables fell 95.83% year-over-year to $117267.0; the TTM figure through Jun 2021 stood at $117267.0 (down 95.83% YoY), while the FY2020 annual figure was $38.7 million, up 3547.09% from the prior year.
- Notes Payables declined to $117267.0 in Q2 2021 per CELZ's latest filing, from $2.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $38.7 million in Q4 2020 and bottomed at $44273.0 in Q2 2017.
- Historically, Notes Payables has averaged $3.1 million across 5 years, with a median of $1.0 million in 2019.
- Annual changes were most pronounced in 2020 — Notes Payables soared 3547.09% — and 2021, when it plunged 95.83%.
- Creative Medical Technology Holdings' Notes Payables stood at $1.3 million in 2017, then jumped by 146.52% to $3.2 million in 2018, then plunged by 67.09% to $1.1 million in 2019, then jumped by 3547.09% to $38.7 million in 2020, then plunged by 99.7% to $117267.0 in 2021.
- Business Quant data shows CELZ's Notes Payables at $117267.0 in Q2 2021, $2.3 million in Q1 2021, and $38.7 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.74 Mn |
| Jun 30, 2021 | 117,267.00 |
| Mar 31, 2021 | 2.28 Mn |
| Dec 31, 2020 | 38.74 Mn |
| Sep 30, 2020 | 1.57 Mn |
| Jun 30, 2020 | 2.81 Mn |
| Mar 31, 2020 | 1.03 Mn |
| Dec 31, 2019 | 1.06 Mn |
| Sep 30, 2019 | 896,246.00 |
| Jun 30, 2019 | 1.07 Mn |
| Mar 31, 2019 | 1.08 Mn |
| Dec 31, 2018 | 3.23 Mn |
| Sep 30, 2018 | 125,000.00 |
| Jun 30, 2018 | 239,980.00 |
| Mar 31, 2018 | 125,000.00 |
| Dec 31, 2017 | 1.31 Mn |
| Sep 30, 2017 | 122,514.00 |
| Jun 30, 2017 | 44,273.00 |
| Mar 31, 2017 | 100,000.00 |
| Sep 30, 2016 | 100,000.00 |